• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Cardiokine

edit

Cardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of cardiovascular diseases. Its products include lixivaptan, an orally active vasopressin receptor antagonist for patients with congestive heart failure who suffer from hyponatremia. The company was founded in 2004 and is headquartered in Philadelphia, Pennsylvania.

Recent Milestones

edit

• 
  Cardiokine was acquired by Cornerstone Therapeutics. (1/4/12)
  Posted 1/4/12 at 9:39pm via dowjones.com
• 
  Cardiokine added Amber Salzman as President and CEO.
  Posted 1/4/12 at 9:35pm
• 
  Cardiokine added Andrew Schiff as director .
  Posted 5/22/13 at 10:17am

Videos

Screenshots

edit

Sources

1. Cornerstone Therapeutics Acquires Cardiokine For Cardiovascular Drug (fis.dowjones.com) [edit]